These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9757039

  • 41. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
    Prosser RA, Dean RR, Edgar DM, Heller HC, Miller JD.
    J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Participation of 5-HT(1B) receptors in the inhibitory actions of serotonin on masculine sexual behaviour of mice: pharmacological analysis in 5-HT(1B) receptor knockout mice.
    Rodríguez-Manzo G, López-Rubalcava C, Hen R, Fernández-Guasti A.
    Br J Pharmacol; 2002 Aug; 136(8):1127-34. PubMed ID: 12163345
    [Abstract] [Full Text] [Related]

  • 47. Effects of 5-HT1A-receptor agonist, 8-OH-DPAT, and GABAB-receptor agonist, baclofen, on lordosis in female rats with lesions in either the dorsal raphe nucleus or septum.
    Kishitake M, Yamanouchi K.
    J Pharmacol Sci; 2005 Aug; 98(4):419-24. PubMed ID: 16079463
    [Abstract] [Full Text] [Related]

  • 48. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

  • 49. Brain region-specific transcriptomic markers of serotonin-1A receptor agonist action mediating sexual rejection and aggression in female marmoset monkeys.
    Aubert Y, Allers KA, Sommer B, de Kloet ER, Abbott DH, Datson NA.
    J Sex Med; 2013 Jun; 10(6):1461-75. PubMed ID: 23551660
    [Abstract] [Full Text] [Related]

  • 50. Effects of FG 5893, a new compound with 5-HT1A receptor agonistic and 5-HT2 receptor antagonistic properties, on male rat sexual behavior.
    Andersson G, Larsson K.
    Eur J Pharmacol; 1994 Apr 01; 255(1-3):131-7. PubMed ID: 8026539
    [Abstract] [Full Text] [Related]

  • 51. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 01; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 52. 8-OH-DPAT in the midbrain central gray inhibits lordosis behavior.
    Uphouse L, Caldarola-Pastuszka M, Droge M.
    Pharmacol Biochem Behav; 1992 Nov 01; 43(3):833-8. PubMed ID: 1448478
    [Abstract] [Full Text] [Related]

  • 53. Serotonin and sexual behavior in the male rabbit.
    Paredes RG, Contreras JL, Agmo A.
    J Neural Transm (Vienna); 2000 Nov 01; 107(7):767-77. PubMed ID: 11005542
    [Abstract] [Full Text] [Related]

  • 54. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
    Alhaider AA, Ageel AM, Ginawi OT.
    Neuropharmacology; 1993 Dec 01; 32(12):1427-32. PubMed ID: 8152532
    [Abstract] [Full Text] [Related]

  • 55. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E.
    Pol J Pharmacol Pharm; 1992 Dec 01; 44(5):427-36. PubMed ID: 1363616
    [Abstract] [Full Text] [Related]

  • 56. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH, Broekkamp CL.
    Br J Pharmacol; 1990 Nov 01; 101(3):667-73. PubMed ID: 2150180
    [Abstract] [Full Text] [Related]

  • 57. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice.
    Alhaider AA, Wilcox GL.
    J Pharmacol Exp Ther; 1993 Apr 01; 265(1):378-85. PubMed ID: 7682614
    [Abstract] [Full Text] [Related]

  • 58. Electrophysiological analyses of serotonergic actions on neurons in hypothalamic ventromedial nucleus in vitro: receptor subtypes involved and implications for regulation of feeding and lordosis behaviors.
    Kow LM, Tsai YF, Wang L, Pfaff DW.
    Chin J Physiol; 1992 Apr 01; 35(2):105-21. PubMed ID: 1451570
    [Abstract] [Full Text] [Related]

  • 59. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A, García-Osta A, Ballaz S, Frechilla D, Del Río J.
    Br J Pharmacol; 1999 Dec 01; 128(8):1691-8. PubMed ID: 10588924
    [Abstract] [Full Text] [Related]

  • 60. Effects of 8-OH-DPAT and WAY-100635 on performance on a time-constrained progressive-ratio schedule.
    Ho MY, Body S, Kheramin S, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2003 May 01; 167(2):137-44. PubMed ID: 12655461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.